Compară metode
Examinează metodele selectate una lângă alta; rândurile care diferă sunt evidențiate.
| Studiu clinic de Fază III ajustat la risc× | Modelul Cox de Hazarduri Proporționale× | |
|---|---|---|
| Domeniu | Epidemiologie | Epidemiologie |
| Familie | Process / pipeline | Process / pipeline |
| Anul apariției≠ | 1980s–present | 1972 |
| Autorul original≠ | Evolving practice; foundational risk-adjustment principles established by Pocock (1983) and extended by numerous trialists | Sir David Roxbee Cox |
| Tip≠ | Confirmatory randomized trial with baseline risk stratification and covariate adjustment | Semi-parametric regression model |
| Sursa seminală≠ | Pocock, S. J. (1983). Clinical Trials: A Practical Approach. Wiley. ISBN: 978-0471901556 | Cox, D. R. (1972). Regression models and life-tables. Journal of the Royal Statistical Society: Series B (Methodological), 34(2), 187–202. DOI ↗ |
| Denumiri alternative | risk-stratified Phase III trial, covariate-adjusted Phase III RCT, risk-adjusted confirmatory trial, RA-Phase III | Cox regression, Cox PH model, proportional hazards model, CPH |
| Înrudite≠ | 6 | 5 |
| Rezumat≠ | A risk-adjusted Phase III clinical trial is a large-scale confirmatory randomized experiment that explicitly incorporates participants' baseline prognostic risk profile into both the randomization process and the primary statistical analysis. By stratifying patients on known risk factors before allocation and adjusting for those factors in the outcome model, the design achieves greater statistical precision, reduces confounding, and produces treatment effect estimates that are more clinically meaningful across patient subgroups. | The Cox proportional hazards model is a semi-parametric regression method that estimates the effect of one or more covariates on the hazard — the instantaneous rate of an event such as death, relapse, or failure — while making no assumption about the shape of the baseline hazard function. Introduced by David Cox in 1972, it is the dominant tool for multivariable survival analysis in clinical and epidemiological research. |
| ScholarGateSet de date ↗ |
|
|